Virbac: TP Icap Midcap upgrades to buy

(CercleFinance.com) - TP Icap Midcap announced on Tuesday that it had upgraded its Buy rating on Virbac from 'Hold' to 'Buy', citing in particular the stock's recent downturn.


In the light of cyclical, monetary, political and geopolitical uncertainties, we believe it is worthwhile to capitalize on animal health, a defensive growth sector", explains the brokerage firm.

Its price target remains unchanged at 389 euros.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.